MCK vs TECH · P/E 20, rev $403.43B vs P/E 65, rev $1.22B
McKesson Corporation (MCK) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MCK and TECH stock pages for the full models.
Not investment advice.